Company Filing History:
2 out of 130 
1 out of 1 Years Active: 2016-2019
Title: Akane Tanaka: Innovator in Retinopathy Research
Introduction
Akane Tanaka is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of medical research, particularly in the area of retinopathy of prematurity (ROP). Her innovative work has led to the development of therapeutic agents and testing methods that address this critical health issue.
Latest Patents
Tanaka holds two notable patents related to retinopathy of prematurity. The first patent is for a therapeutic or prophylactic agent for ROP, which utilizes inhibitors against tryptase derived from mast cells and/or mast cell stabilizers as active ingredients. This agent is designed to align with the pathogenic mechanisms of ROP. The second patent involves a testing method for ROP, which includes detecting a marker substance released by mast cells in a biological sample. This method allows for the determination of the presence or absence of ROP based on the detected amount of the marker.
Career Highlights
Throughout her career, Akane Tanaka has worked with esteemed institutions such as the Tokyo University of Agriculture and Technology and Japan Innovation Therapeutics, Inc. Her research has focused on developing effective treatments and testing methods for ROP, showcasing her dedication to improving patient outcomes.
Collaborations
Tanaka has collaborated with notable colleagues, including Hiroshi Matsuda and Akira Matsuda. These partnerships have further enhanced her research efforts and contributed to the advancement of knowledge in her field.
Conclusion
Akane Tanaka's innovative work in the realm of retinopathy of prematurity has made a significant impact on medical research. Her patents and collaborations reflect her commitment to addressing critical health challenges.